• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to secondary sidebar

GAiT.Global

The Global Alliance for iPSC Therapies

  • About GAiT
    • About GAiT
    • Sponsors
      • NYSCF
      • KHiB
      • CCRM
      • INSERM / Cithera /INGESTEM
      • HKU
      • CGT
    • Support Us
  • News & Events
  • Publications
  • Workshops
  • iPSC Quality Assessment Rounds
    • iPSC Quality Assessment Round 2022/2023
      • iPSC Quality Assessment Round 2022 – Document Page
  • Directories
  • Clinical Database
  • Portal Login
You are here: Home / ISSCR Clinical Translation Committee

ISSCR Clinical Translation Committee

The International Society for Stem Cell Research (www.isscr.org) supports all forms of stem cell research and application, including induced pluripotent stem cells.

Of particular interest of GAiT members will be ISSCR’s Clinical Translation Committee. GAiT Director Prof Jihwan Song is a member of this committee.

http://engage.isscr.org/CommitteeDetail?CommCode=CLINCOMM

GAiT Director Prof Ron Li spoke at the committee’s workshop on clinical translation in 2020.

https://www.isscr.org/meetings-events/annual-meetings/isscr-annual-meeting-2020/program/sessions-events-descriptions/pre-meeting-education

Mission of the ISSCR’s Clinical Translation Committee

  • Develop a strong and active translational and clinical presence within the ISSCR that reflects its growing impact within society.
  • Provide leadership and develop strategy for the programs that support scientists, physicians, regulatory agencies and industry in the translation and development of stem cell-based therapies.
  • Provide leadership in and support for developing programs and messages for the public on the application and use of stem cell-based therapies in a scientifically rigorous and ethical manner

Significant activities of the ISSCR’s Clinical Translation Committee

  • Practical Advice for Physicians and Ethics / Institutional Review Committees. The ISSCR’s “Stem Cell-Based Clinical Trials: Practical Advice for Physicians and Ethics/Institutional Review Committees” provides background and fundamental questions for clinicians and ethics / institutional review committees to ask when considering running or reviewing early phase, cell-based clinical trials.

http://www.isscr.org/scientific-clinical-resources/stem-cell-based-clinical-trials

  • Disease Fact Sheets. These physician-focused, concise highlights provide the current state of stem cell science for specific diseases, including background on the disease, rationale for using cell-based therapies, evidence for specific approaches and current status of the field with respect to clinical trials. There are currently fact sheets on 11 different diseases.

https://www.isscr.org/scientific-clinical-resources/disease-fact-sheets

  • Disease Fact Sheets. The fact sheets for physicians were “translated” to be suitable to public understanding and placed on the ISSCR’s public website, A Closer Look at Stem Cells.
Disease Fact Sheets
  • Advising on ISSCR on translationally-related activities as needed. This includes:
    • Meeting content, such as the Workshop on Clinical Translation
    • Informed Consent Standard for Stem Cell-Based Interventions. This document outlines a professional standard for the information that needs to be provided to patients (or their legally valid surrogates) to help position them to make an informed decision if offered stem cell-based interventions outside of a formal clinical trial. https://www.isscr.org/scientific-clinical-resources/informed-consent-standard-for-stem-cell-based-interventions

Primary Sidebar

Search Users

Secondary Sidebar

Invite Users to Site

Invite another user onto the GAiT Website
Invite Users

Social media

Follow us on social media

GAiT LinkedIn GAit Sound Cloud GAiT Twitter

 

 

Newsletter





© 2023 GAiT. All Rights reserved. Web Design by Conceptstore
  • Home
  • Portal Login